| Matthew C Musielak, MD | |
|
4 Memorial Dr Ste 230b, Alton, IL 62002-6751 | |
| (618) 463-7833 | |
| Not Available |
| Full Name | Matthew C Musielak |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 15 Years |
| Location | 4 Memorial Dr Ste 230b, Alton, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477781177 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2009017790 (Missouri) | Secondary |
| 208600000X | Surgery | 036148189 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alton Memorial Hospital | Alton, IL | Hospital |
| Christian Hospital Northeast | Saint louis, MO | Hospital |
| Barnes Jewish Hospital | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Heights Medical Group Sc | 6800784083 | 342 |
News Archive
A team of scientists from Germany has recently evaluated the reactogenicity profile of heterologous ChAdOx1 nCoV-19/BNT162b2 prime-boost vaccination among healthcare workers. The findings reveal that a 12-week interval regimen of heterologous vaccination is well-tolerated among participants. The study is currently available on the medRxiv* preprint server.
A new online and searchable European register of clinical trials in children, which has been developed in collaboration with academics at The University of Nottingham and will make the practice of paediatric medicine safer and more effective, has recently been launched.
Pancreatic ductal adenocarcinoma is one of the most aggressive and deadliest forms of cancer. Treatment options are limited because symptoms typically do not appear until the disease is advanced and complete surgical resection of tumors is not possible.
Tercica announced today the filing of a suit for patent infringement in the High Court of Justice (Chancery Division Patents Court) in the United Kingdom against Insmed Incorporated of Glen Allen, Virginia and Avecia Limited of the United Kingdom.
› Verified 6 days ago
| Entity Name | Fairview Heights Medical Group Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679503668 PECOS PAC ID: 6800784083 Enrollment ID: O20040309000650 |
News Archive
A team of scientists from Germany has recently evaluated the reactogenicity profile of heterologous ChAdOx1 nCoV-19/BNT162b2 prime-boost vaccination among healthcare workers. The findings reveal that a 12-week interval regimen of heterologous vaccination is well-tolerated among participants. The study is currently available on the medRxiv* preprint server.
A new online and searchable European register of clinical trials in children, which has been developed in collaboration with academics at The University of Nottingham and will make the practice of paediatric medicine safer and more effective, has recently been launched.
Pancreatic ductal adenocarcinoma is one of the most aggressive and deadliest forms of cancer. Treatment options are limited because symptoms typically do not appear until the disease is advanced and complete surgical resection of tumors is not possible.
Tercica announced today the filing of a suit for patent infringement in the High Court of Justice (Chancery Division Patents Court) in the United Kingdom against Insmed Incorporated of Glen Allen, Virginia and Avecia Limited of the United Kingdom.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew C Musielak, MD 4 Memorial Dr Ste 230b, Alton, IL 62002-6751 Ph: (618) 463-7833 | Matthew C Musielak, MD 4 Memorial Dr Ste 230b, Alton, IL 62002-6751 Ph: (618) 463-7833 |
News Archive
A team of scientists from Germany has recently evaluated the reactogenicity profile of heterologous ChAdOx1 nCoV-19/BNT162b2 prime-boost vaccination among healthcare workers. The findings reveal that a 12-week interval regimen of heterologous vaccination is well-tolerated among participants. The study is currently available on the medRxiv* preprint server.
A new online and searchable European register of clinical trials in children, which has been developed in collaboration with academics at The University of Nottingham and will make the practice of paediatric medicine safer and more effective, has recently been launched.
Pancreatic ductal adenocarcinoma is one of the most aggressive and deadliest forms of cancer. Treatment options are limited because symptoms typically do not appear until the disease is advanced and complete surgical resection of tumors is not possible.
Tercica announced today the filing of a suit for patent infringement in the High Court of Justice (Chancery Division Patents Court) in the United Kingdom against Insmed Incorporated of Glen Allen, Virginia and Avecia Limited of the United Kingdom.
› Verified 6 days ago
Dr. James A Kliefoth, MD Surgery Medicare: Medicare Enrolled Practice Location: 1 Professional Dr, Ste 150, Alton, IL 62002 Phone: 618-463-8660 Fax: 618-463-8666 | |
Dr. Christopher Ryan Aldridge, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 230, Alton, IL 62002 Phone: 618-463-7833 | |
Raman Kumar, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Saint Anthonys Way Ste 305, Alton, IL 62002 Phone: 618-465-9024 Fax: 618-462-6828 | |
Dr. Paolo Masetti, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7311 Fax: 636-333-4510 | |
John D. Zander, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1751 Washington Ave, Alton, IL 62002 Phone: 773-839-9794 | |
Dr. Shoichiro Alberto Tanaka, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Memorial Dr, Div Surg Plastics, Ste 101, Alton, IL 62002 Phone: 618-433-6131 Fax: 618-433-6128 |